Saxenda® Liraglutide is an FDA-approved injectable GLP-1 weight loss medication. It is clinically proven to help patients lose up to 10% of their body weight, and 85% of people treated with Saxenda® Liraglutide lost weight. Available from just ₱3,380 with an online prescription and same-day delivery.
*In a 68- and 72-week clinical trial studying GLP-1 in patients without diabetes and with BMI ≥30, or BMI ≥27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone).
A smart digital weighing scale that measures 12 body parameters to help you track your weight and health.
Pick the treatment plan you want. Our Doctors recommend the longer plans for new users and best results.
OVA’s weight loss plans are co-designed with Dr. Ben Ng, Singapore’s leading endocrinologist and Chief Medical Officer at OVA. A senior consultant with over 20 years of clinical experience, Dr. Ng is renowned for his expertise in diagnosing and treating obesity, diabetes, thyroid disorders, and a broad spectrum of metabolic and endocrine conditions.
A prescription oral GLP-1 receptor agonist that helps manage type 2 diabetes by lowering blood sugar levels, stimulating insulin production, and supporting weight management.
A prescription oral GLP-1 receptor agonist that helps manage type 2 diabetes by lowering blood sugar levels, stimulating insulin production, and supporting weight management.
A prescription oral GLP-1 receptor agonist that helps manage type 2 diabetes by lowering blood sugar levels, stimulating insulin production, and supporting weight management.
